| cpd00992 | 1176834-48-2 | | AAGYLLGKINLKALAALAKKIL | firefly luciferin derivative | Diagnosis, luciferin–CPP conjugate uptake and cytosolic cargo release | disulfide | Eiriksdottir, Emelia;et.al (2009)
DOI |
cpd00993 | 1176834-47-1 | | AMVTVLFRRLRIRRASGPPRVRV | firefly luciferin derivative | Diagnosis, luciferin–CPP conjugate uptake and cytosolic cargo release | disulfide | Eiriksdottir, Emelia;et.al (2009)
DOI | cpd00994 | 1176834-46-0 | | ALLIILRRRIRKQAHAHSK | firefly luciferin derivative | Diagnosis, luciferin–CPP conjugate uptake and cytosolic cargo release | disulfide | Eiriksdottir, Emelia;et.al (2009)
DOI | cpd00995 | 1167995-16-5 | | GILKEPVHGA | 9,12-Octadecadienoic acid (9Z,12Z)-, hydrazide | Synthesis, novel ligation method (azaGly ligation) | hydrazide | Ollivier, Nathalie;et.al (2009)
DOI | cpd00996 | 1167995-15-4 | | GILKEPVHGA | (9Z)-9-Octadecenoic acid hydrazide | Synthesis, novel ligation method (azaGly ligation) | hydrazide | Ollivier, Nathalie;et.al (2009)
DOI | cpd00997 | 1167995-14-3 | | GILKEPVHGA | Cholest-5-en-3-ol (3β)-, 3-(hydrazinecarboxylate) | Synthesis, novel ligation method (azaGly ligation) | carbamate | Ollivier, Nathalie;et.al (2009)
DOI | cpd00998 | 864282-42-8 | | EGFLG | Methotrexate | Osteoarthritis | amide | Homma, Akie;et.al (2009)
DOI | cpd00999 | 864282-41-7 | tetrapeptide | ENFF | Methotrexate | Osteoarthritis | amide | Homma, Akie;et.al (2009)
DOI | cpd01000 | 864282-49-5 | | XGFLG | Methotrexate | Osteoarthritis | amide | Homma, Akie;et.al (2009)
DOI | cpd01001 | 1177418-04-0 | tetrapeptide | ENFF | Methotrexate | Osteoarthritis | amide | Homma, Akie;et.al (2009)
DOI | cpd01002 | 1199559-05-1 | tripeptide | AAC | 3-Methoxyestra-1,3,5(10),16-tetraeno[17,16-d]pyrimidin-2′-amine | Diagnostic, detection of estrogen positive breast cancer cells | amide | Matsumoto, Tomohiro;et.al (2009)
DOI | cpd01003 | 1199559-04-0 | tetrapeptide | XSAS | 3-Methoxyestra-1,3,5(10),16-tetraeno[17,16-d]pyrimidin-2′-amine | Diagnostic, detection of estrogen positive breast cancer cells | amide | Matsumoto, Tomohiro;et.al (2009)
DOI | cpd01004 | 1199559-03-9 | tetrapeptide | XSGS | 3-Methoxyestra-1,3,5(10),16-tetraeno[17,16-d]pyrimidin-2′-amine | Diagnostic, detection of estrogen positive breast cancer cells | amide | Matsumoto, Tomohiro;et.al (2009)
DOI | cpd01005 | 1199559-02-8 | tripeptide | SGC | 3-Methoxyestra-1,3,5(10),16-tetraeno[17,16-d]pyrimidin-2′-amine | Diagnostic, detection of estrogen positive breast cancer cells | amide | Matsumoto, Tomohiro;et.al (2009)
DOI | cpd01006 | 1199558-92-3 | tripeptide | SAS | 3-(Phenylmethoxy)estra-1,3,5(10),16-tetraeno[17,16-d]pyrimidin-2′-amine | Diagnostic, detection of estrogen positive breast cancer cells | amide | Matsumoto, Tomohiro;et.al (2009)
DOI | cpd01007 | 1199558-91-2 | tripeptide | SGS | 3-(Phenylmethoxy)estra-1,3,5(10),16-tetraeno[17,16-d]pyrimidin-2′-amine | Diagnostic, detection of estrogen positive breast cancer cells | amide | Matsumoto, Tomohiro;et.al (2009)
DOI | cpd01008 | 1199558-90-1 | tetrapeptide | XSGS | 3-(Phenylmethoxy)estra-1,3,5(10),16-tetraeno[17,16-d]pyrimidin-2′-amine | Diagnostic, detection of estrogen positive breast cancer cells | amide | Matsumoto, Tomohiro;et.al (2009)
DOI | cpd01009 | 1160497-06-2 | | EVTCVVVD | Biotin | Synthesis, Increasing of water solubility | amide | Bartos, Adam;et.al (2009)
DOI | cpd01010 | 1160497-04-0 | | EVTCVVVD | Biotin | Synthesis, Increasing of water solubility | amide | Bartos, Adam;et.al (2009)
DOI | cpd01011 | 1160497-03-9 | | EVTCVVVD | Biotin | Synthesis, Increasing of water solubility | amide | Bartos, Adam;et.al (2009)
DOI | cpd01012 | 1142929-84-7 | | AXAXQAXAX | N-[2-[2-(4-Nitrophenyl)ethynyl]-5-(2-phenylethynyl)phenyl]acetamide | Possible medical and electronic applications | amide | Nakayama, Hidenori;et.al (2009)
DOI | cpd01013 | 1142929-83-6 | | QAXAX | N-[2-[2-(4-Nitrophenyl)ethynyl]-5-(2-phenylethynyl)phenyl]acetamide | Possible medical and electronic applications | amide | Nakayama, Hidenori;et.al (2009)
DOI | cpd01014 | 1166993-87-8 | tetrapeptide | RGDV | Estradiol | Osteoporosis therapy | amide | Zhao, Ming;et.al (2009)
DOI | cpd01015 | 1166993-86-7 | tetrapeptide | RGDS | Estradiol | Osteoporosis therapy | amide | Zhao, Ming;et.al (2009)
DOI | cpd01016 | 1166993-84-5 | tetrapeptide | RGDV | Estradiol | Osteoporosis therapy | amide | Zhao, Ming;et.al (2009)
DOI | cpd01017 | 1166993-76-5 | tetrapeptide | RGDF | Estradiol | Osteoporosis therapy | amide | Zhao, Ming;et.al (2009)
DOI | cpd01018 | 1166993-74-3 | tetrapeptide | RGDV | Estradiol | Osteoporosis therapy | amide | Zhao, Ming;et.al (2009)
DOI | cpd01019 | 1166993-72-1 | tetrapeptide | RGDS | Estradiol | Osteoporosis therapy | amide | Zhao, Ming;et.al (2009)
DOI | cpd01020 | 1166993-64-1 | | RGDFRGDF | Estradiol | Osteoporosis therapy | amide | Zhao, Ming;et.al (2009)
DOI | cpd01021 | 1166993-63-0 | | RGDVRGDV | Estradiol | Osteoporosis therapy | amide | Zhao, Ming;et.al (2009)
DOI |